Advanced search
Publication Cover
Expert Review of Endocrinology & Metabolism Volume 8, 2013 - Issue 5
Submit an article Journal homepage
429
Views
4
CrossRef citations to date
0
Altmetric
Editorials

Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome

Thomas M BarberDivision of Metabolic and Vascular Health, Warwick Medical School, Clinical Sciences Research Laboratories, University Hospitals Coventry and Warwickshire, Clifford Bridge Road, Coventry, CV2 2DX, [email protected]
&
Stephen FranksInstitute of Reproductive and Developmental Biology (S.F.), Imperial College (Hammersmith Campus) London, W12 0NN, UK+44 20 7594 2109/2176+44 20 7594 2184
Pages 427-429 | Published online: 10 Jan 2014

References

  • Barber TM, Mccarthy MI,Wass JA,Franks S. Obesity and polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 65(2), 137–145 (2006).
  • Barber TM, Mccarthy MI, Franks S, Wass JA. Metabolic syndrome in polycystic ovary syndrome. Endokrynol. Pol. 58(1), 34–41 (2007).
  • Barber TM, Bennett AJ, Groves CJ et al. Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome. Diabetologia 51(7), 1153–1158 (2008).
  • Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J. Clin. Endocrinol. Metab. 85(7), 2434–2438 (2000).
  • The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19(1), 41–47 (2004).
  • Zawadzki J, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Polycystic ovary syndrome. Dunaif A GJ, Haseltine Fp, Merriam Gr (Eds). Blackwell Scientific, Boston, 377–384 (1992).
  • Wild S, Pierpoint T, Mckeigue P, Jacobs H. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin. Endocrinol. (Oxf.) 52(5), 595–600 (2000).
  • Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr. Rev. 33(6), 981–1030 (2012).
  • Morin-Papunen LC, Vauhkonen I, Koivunen RM, Ruokonen A, Tapanainen JS. Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome. Hum. Reprod. 15(6), 1266–1274 (2000).
  • Willis DS, Watson H, Mason HD, Galea R, Brincat M, Franks S. Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. J. Clin. Endocrinol. Metab. 83(11), 3984–3991 (1998).
  • Barber TM, Wass JA, Mccarthy MI, Franks S. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 66(4), 513–517 (2007).
  • Robinson S, Kiddy D, Gelding SV et al. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin. Endocrinol. (Oxf.) 39(3), 351–355 (1993).
  • Dewailly D, Catteau-Jonard S, Reyss AC, Leroy M, Pigny P. Oligo-anovulation with Polycystic Ovaries (PCO) but not overt hyperandrogenism. J. Clin. Endocrinol. Metab. 91(10), 3922–3927 (2006).
  • Welt CK, Gudmundsson JA, Arason G et al. Characterizing Discrete Subsets of Polycystic Ovary Syndrome as Defined by the Rotterdam Criteria: the Impact of Weight on Phenotype and Metabolic Features. J. Clin. Endocrinol. Metab. 91(12), 4842–4848 (2006).
  • Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC. PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG 113(10), 1210–1217 (2006).
  • Ciftci CF, Uckuyu A, Karadeli E, Turhan E, Toprak E, Ozcimen EE. Phenotypic subgroups of polycystic ovary syndrome have different intra-renal resistance symptoms. Ginekol. Pol. 83(12), 910–915 (2012).
  • Vaggopoulos V, Trakakis E, Chrelias C et al. Comparing classic and newer phenotypes in Greek PCOS women: the prevalence of Metabolic Syndrome and their association with Insulin Resistance. J. Endocrinol. Invest. 36(7), 478–484 (2012).
  • Zhang HY, Zhu FF, Xiong J, Shi XB, Fu SX. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population. BJOG 116(12), 1633–1639 (2009).
  • Moghetti P, Tosi F, Bonin C et al. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 98(4), E628–E637 (2013).
  • Barber TM, Franks S. Genetic basis of polycystic ovary syndrome. Expert Rev. Endocrinol. Metab. 5(4), 549–561 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.